We investigated the knowledge of cystic fibrosis and the views about neonatal and carrier screening in 216 school students aged 14 to 16 years. This work was completed before the published identification of the cystic fibrosis gene in September 1989. Although initial knowledge of cystic fibrosis was low (only 17% of the students knew that the disease affected the lungs), there was good recall of basic information about cystic fibrosis and of recessive inheritance after a brief lecture. A total of 86% considered that carrier detection should be offered routinely and 88% felt that an offer of prenatal diagnosis for cystic fibrosis should be made if both prospective parents were known to be carriers. We believe that pilot studies of cystic fibrosis carrier screening in schools should be undertaken.
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The identification of the cystic fibrosis (CF) gene and of its major mutations' 2 has made it feasible to screen large populations for the carrier state. In the UK around 4-6% of Caucasians are carriers and of these about 77% could now be detected by molecular genetic techniques.3 Screening of couples before pregnancy, or in the first trimester, would therefore provide an opportunity for genetic counselling of those couples in which both partners were CF heterozygotes. This would give such high risk couples options which were previously available only to those who had an affected subject in their family. Table 2 shows the change observed immediately after the short lectures. After the short talks on cystic fibrosis, 88% knew that to be affected a subject required two recessive genes, one from the mother and one from the father, 98% knew that carriers had no disease, and 990/o knew that the average lifespan was considerably reduced. Table 3 shows the views about neonatal screening. A very large majority considered that neonatal testing was a good idea and that it should be routine. Of the pupils who understood enough about CF, 95% were in favour of neonatal screening. Table 4 shows that of all the pupils questioned, 86% thought that routine carrier screening should be offered and 87% thought that prenatal diagnosis should be offered if both parents were found to be carriers. Of the 71% who understood the genetic principles behind carrier detection and the risks of amniocentesis, 86% were for routine carrier screening and 88% were for offering prenatal diagnosis to carrier parents. Those who were in the third year classes at the time of our study will now be approaching the stage when carrier screening might be offered, either in a preconception situation at health centres and family planning clinics, or during the early stages of a pregnancy. Our main findings suggest that these subjects would be in favour of both neonatal screening for CF and also of screening for carriers. We feel that, in the hypothetical situation which we presented, the influence of family pressures and attitudes was reduced. Also, in our study, the attitudes were not influenced by the actual availability of a carrier test or by the imminent need to decide about prenatal diagnosis, as would occur in young pregnant women. There would seem to be a very positive attitude to carrier screening and to the offer of prenatal tests of those couples shown both to be carriers.
Before setting up carrier screening programmes for carriers of Tay-Sachs disease in Montreal, pilot programmes were established to determine the most effective approaches. 10 Community leaders helped with such studies to determine the expectations of this type of preventative medicine, taking into account the previous education of the community and the need for follow up counselling. A study ofhaemoglobinopathies by Scriver et all' showed that the highest response to carrier screening was by school pupils, and Williamson et al4 reported that 77% of school pupils (aged 16 to 18) favour carrier testing. Therefore, we think that the later school years would be the best time to offer carrier detection for cystic fibrosis, rather than at antenatal clinics, as suggested for the thalassaemias by Mouzouras et al. 12 However, since most pupils would be under the age of 18 when offered testing, their parents and also the wider community would have to be involved.
Taken as a whole, our results, and those of 
